Metropolitan Life Insurance Company (MetLife)’s Nano X Imaging NNOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,542
Closed -$24.8K 1387
2024
Q1
$24.8K Hold
2,542
﹤0.01% 1754
2023
Q4
$16.2K Hold
2,542
﹤0.01% 2005
2023
Q3
$16.7K Hold
2,542
﹤0.01% 1982
2023
Q2
$39.4K Buy
+2,542
New +$35.2K ﹤0.01% 1571
2023
Q1
Sell
-2,956
Closed -$21.8K 2413
2022
Q4
$21.8K Buy
2,956
+237
+9% +$2.63K ﹤0.01% 1968
2022
Q3
$31.2K Hold
2,719
﹤0.01% 1780
2022
Q2
$30.7K Buy
+2,719
New +$28.3K ﹤0.01% 1803

Other funds holding NNOX

Metropolitan Life Insurance Company (MetLife)'s NNOX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nano X Imaging (NNOX) in Q2 2024, closing a stake of 2,542 shares — an estimated $24.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NNOX in Q2 2022 and held it in 7 quarters. The position peaked at $39.4K in Q2 2023. 105 funds tracked by Wall St. Rank hold NNOX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nano X Imaging position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,542 Nano X Imaging shares in Q2 2024, an estimated $24.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nano X Imaging in Q2 2022 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nano X Imaging position peaked at $39.4K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Nano X Imaging as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.